Protective effect of anthocyanins in middle cerebral artery occlusion and reperfusion model of cerebral ischemia in rats

Life Sciences

Volumn 79, Issue 2, 2006, Pages 130-137

  Shin, Won Ho ^a   Park, Sang Joon ^a   Kim, Eun Joo ^a  

^a Korea Research Institute of Chemical Technology   (South Korea)

Author keywords

Anthocyanins; Apoptosis; c Jun N terminal kinase; Cerebral focal ischemia; p53

Indexed keywords

ANTHOCYANIN; PROTEIN P53; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NICK END LABELING; NONHUMAN; RAT; REPERFUSION INJURY; WESTERN BLOTTING;

ANIMALS; ANTHOCYANINS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOTTING, WESTERN; BRAIN ISCHEMIA; CELL COUNT; IMMUNOHISTOCHEMISTRY; INFARCTION, MIDDLE CEREBRAL ARTERY; ISCHEMIC ATTACK, TRANSIENT; MALE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33646711480     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2005.12.033     Document Type: Article

References (38)

1. Amorini A.M., Lazzarino G., Galvano F., Fazzina G., Tavazzi B., and Galvano G. Cyanidin-3-O-beta-glucopyranoside protects myocardium and erythrocytes from oxygen radical-mediated damages. Free Radical Research 37 4 (2003) 453-460
2. Andrabi S.A., Sayeed I., Siemen D., Wolf G., and Horn T.F. Direct inhibition of the mitochondrial permeability transition pore: a possible mechanism responsible for anti-apoptotic effects of melatonin. The FASEB Journal 18 7 (2004) 869-871
3. Borsello T., Clarke P.G., Hirt L., Vercelli A., Repici M., Schorderet D.F., Bogousslavsky J., and Bonny C. A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia. Nature Medicine 9 9 (2003) 1180-1186
4. Carboni S., Hiver A., Szyndralewiez C., Gaillard P., Gotteland J.P., and Vitte P.A. AS601245 (1,3-benzothiazol-2-yl (2-[[2-(3-pyridinyl) ethyl] amino]-4 pyrimidinyl) acetonitrile): a c-Jun NH2-terminal protein kinase inhibitor with neuroprotective properties. The Journal of Pharmacology and Experimental Therapeutics 310 1 (2004) 25-32
5. Charriaut-Marlangue C., Aggoun-Zouaoui D., Represa A., and Ben-Ari Y. Apoptotic features of selective neuronal death in ischemia, epilepsy and gp 120 toxicity. Trends in Neurosciences 19 3 (1996) 109-114
6. Cheung R.T., Pei Z., Feng Z.H., and Zou L.Y. Cyclooxygenase-1 gene knockout does not alter middle cerebral artery occlusion in a mouse stroke model. Neuroscience Letters 330 1 (2002) 57-60
7. Dirnagl U., Iadecola C., and Moskowitz M.A. Pathobiology of ischaemic stroke: an integrated view. Trends in Neurosciences 22 9 (1999) 391-397
8. Felgines C., Texier O., Besson C., Fraisse D., Lamaison J.L., and Remesy C. Blackberry anthocyanins are slightly bioavailable in rats. Journal of Nutrition 132 6 (2002) 1249-1253
9. Ferrer I., Friguls B., Dalfo E., and Planas A.M. Early modifications in the expression of mitogen-activated protein kinase (MAPK/ERK), stress-activated kinases SAPK/JNK and p38, and their phosphorylated substrates following focal cerebral ischemia. Acta Neuropathologica (Berl) 105 5 (2003) 425-437
10. Gao Y., Signore A.P., Yin W., Cao G., Yin X.M., Sun F., Luo Y., Graham S.H., and Chen J. Neuroprotection against focal ischemic brain injury by inhibition of c-Jun N-terminal kinase and attenuation of the mitochondrial apoptosis-signaling pathway. Journal of Cerebral Blood Flow and Metabolism 25 6 (2005) 694-712
11. Harris C.A., Deshmukh M., Tsui-Pierchala B., Maroney A.C., and Johnson Jr. E.M. Inhibition of the c-Jun N-terminal kinase signaling pathway by the mixed lineage kinase inhibitor CEP-1347 (KT7515) preserves metabolism and growth of trophic factor-deprived neurons. Journal of Neuroscience 22 1 (2002) 103-113
12. Hayashi T., Sakai K., Sasaki C., Zhang W.R., Warita H., and Abe K. c-Jun N-terminal kinase (JNK) and JNK interacting protein response in rat brain after transient middle cerebral artery occlusion. Neuroscience Letters 284 3 (2000) 195-199
13. Hou D.X., Kai K., Li J.J., Lin S., Terahara N., Wakamatsu M., Fujii M., Young M.R., and Colburn N. Anthocyanidins inhibit activator protein 1 activity and cell transformation: structure-activity relationship and molecular mechanisms. Carcinogenesis 25 1 (2004) 29-36
14. Hou D.X., Yanagita T., Uto T., Masuzaki S., and Fujii M. Anthocyanidins inhibit cyclooxygenase-2 expression in LPS-evoked macrophages: structure-activity relationship and molecular mechanisms involved. Biochemical Pharmacology 70 3 (2005) 417-425
15. Iadecola C., and Alexander M. Cerebral ischemia and inflammation. Current Opinion in Neurology 14 1 (2001) 89-94
16. Irving E.A., and Bamford M. Role of mitogen- and stress-activated kinases in ischemic injury. Journal of Cerebral Blood Flow and Metabolism 22 6 (2002) 631-647
17. Keuker J.I., Vollmann-Honsdorf G.K., and Fuchs E. How to use the optical fractionator: an example based on the estimation of neurons in the hippocampal CA1 and CA3 regions of tree shrews. Brain Research Protocols 7 3 (2001) 211-221
18. Krupinski J., Slevin M., Marti E., Catena E., Rubio F., and Gaffney J. Time-course phosphorylation of the mitogen activated protein (MAP) kinase group of signalling proteins and related molecules following middle cerebral artery occlusion (MCAO) in rats. Neuropathology and Applied Neurobiology 29 2 (2003) 144-158
19. Leker R.R., and Shohami E. Cerebral ischemia and trauma-different etiologies yet similar mechanisms: neuroprotective opportunities. Brain Research Reviews 39 1 (2002) 55-73
20. Li Y., Chopp M., Powers C., and Jiang N. Apoptosis and protein expression after focal cerebral ischemia in rat. Brain Research 765 2 (1997) 301-312
21. Linnik M.D., Zobrist R.H., and Hatfield M.D. Evidence supporting a role for programmed cell death in focal cerebral ischemia in rats. Stroke 24 12 (1993) 2002-2008 (discussion 8-9)
22. Lipton P. Ischemic cell death in brain neurons. Physiological Reviews 79 4 (1999) 1431-1568
23. Mergenthaler P., Dirnagl U., and Meisel A. Pathophysiology of stroke: lessons from animal models. Metabolic Brain Disease 19 3-4 (2004) 151-167
24. Miyazawa T., Nakagawa K., Kudo M., Muraishi K., and Someya K. Direct intestinal absorption of red fruit anthocyanins, cyanidin-3-glucoside and cyanidin-3,5-diglucoside, into rats and humans. Journal of Agricultural and Food Chemistry 47 3 (1999) 1083-1091
25. Park S.W., Kim Y.B., Hwang S.N., Choi D.Y., Kwon J.T., Min B.K., and Suk J.S. The effects of N-methyl-N-nitrosourea and azoxymethane on focal cerebral infarction and the expression of p53, p21 proteins. Brain Research 855 2 (2000) 298-306
26. Paxinos G.., and Watson C. The Rat Brains in Stereotaxic Coordinates (1986), Academic Press, San Diego
27. Ramirez-Tortosa C., Andersen O.M., Gardner P.T., Morrice P.C., Wood S.G., Duthie S.J., Collins A.R., and Duthie G.G. Anthocyanin-rich extract decreases indices of lipid peroxidation and DNA damage in vitamin E-depleted rats. Free Radical Biology & Medicine 31 9 (2001) 1033-1037
28. Renolleau S., Benjelloun N., Ben-Ari Y., and Charriaut-Marlangue C. Regulation of apoptosis-associated proteins in cell death following transient focal ischemia in rat pups. Apoptosis 2 4 (1997) 368-376
29. Rossi A., Serraino I., Dugo P., Di Paola R., Mondello L., Genovese T., Morabito D., Dugo G., Sautebin L., Caputi A.P., and Cuzzocrea S. Protective effects of anthocyanins from blackberry in a rat model of acute lung inflammation. Free Radical Research 37 8 (2003) 891-900
30. Shackelford D.A., and Yeh R.Y. Differential effects of ischemia and reperfusion on c-Jun N-terminal kinase isoform protein and activity. Molecular Brain Research 94 1-2 (2001) 178-192
31. Sugino T., Nozaki K., Takagi Y., Hattori I., Hashimoto N., Moriguchi T., and Nishida E. Activation of mitogen-activated protein kinases after transient forebrain ischemia in gerbil hippocampus. The Journal of Neuroscience 20 12 (2000) 4506-4514
32. Tamura A., Graham D.I., McCulloch J., and Teasdale G.M. Focal cerebral ischaemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. Journal of Cerebral Blood Flow and Metabolism 1 1 (1981) 53-60
33. Tournier C., Hess P., Yang D.D., Xu J., Turner T.K., Nimnual A., Bar-Sagi D., Jones S.N., Flavell R.A., and Davis R.J. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 288 5467 (2000) 870-874
34. Tsuda T., Horio F., Kitoh J., and Osawa T. Protective effects of dietary cyanidin 3-O-beta-D-glucoside on liver ischemia-reperfusion injury in rats. Archives of Biochemistry and Biophysics 368 2 (1999) 361-366
35. Tsuda T., Horio F., and Osawa T. Cyanidin 3-O-beta-D-glucoside suppresses nitric oxide production during a zymosan treatment in rats. Journal of Nutritional Science and Vitaminology (Tokyo) 48 4 (2002) 305-310
36. Warner D.S., Sheng H., and Batinic-Haberle I. Oxidants, antioxidants and the ischemic brain. Journal of Experimental Biology 207 Pt18 (2004) 3221-3231
37. White B.C., Sullivan J.M., DeGracia D.J., O'Neil B.J., Neumar R.W., Grossman L.I., Rafols J.A., and Krause G.S. Brain ischemia and reperfusion: molecular mechanisms of neuronal injury. Journal of the Neurological Sciences 179 S1-S2 (2000) 1-33
38. Youdim K.A., Dobbie M.S., Kuhnle G., Proteggente A.R., Abbott N.J., and Rice-Evans C. Interaction between flavonoids and the blood-brain barrier: in vitro studies. Journal of Neurochemistry 85 1 (2003) 180-192